We are your partners in delivering on the promise of creative science from discovery through development.

Unlike traditional advisors, Tara embeds systems-level thinking to help translate innovation into meaningful outcomes faster and to scale more sustainably.

Our focus is on establishing the conditions for great ideas to thrive by helping you design integrated strategies, operating models, and thriving cultures that work together to achieve your goals.

What We Solve

Ineffective systems are what get in the way of enabling progress. Biotech companies at all stages of growth and maturity face recurring and predictable friction points that slow progress, waste capital, and hinder translation of innovative ideas to successful outcomes.

We specialize in:

  • Accelerating projects from research to clinic

  • Designing organizations to scale effectively

  • Identifying and overcoming barriers to innovation

  • Developing high performance teams and leaders

Our Approach

Tara Bioscience carries a symbolic connotation that references a clear and conscious vision for transforming the current biotech model through a more interconnected approach to scientific innovation. We are your partner in building organizations that work, for investors and patients.


 We empower clients to identify barriers and create self-sustaining solutions.            

  • Scientific and analytic rigor: Ensure a quality foundation for successful innovation

  • Translational Integration: Consider the end goal at every step 

  • Organizational Clarity: Integrate functional teams using minimum-viable process 

  • Cultural Fluency: Build a values-driven, high-functioning culture that can delive

Dr. Jessica Couch and Laura Kahn founded Tara Bioscience to bring their deep experience spanning drug discovery, development, and organizational transformation to a new portfolio of clients throughout the biopharma industry. Together, they bring a proven track record of advancing breakthrough science, building high-performing teams, and delivering innovative therapies to patients. With complementary expertise across portfolio strategy, translational science, and operational excellence, Jess and Laura are dedicated to helping biotech teams realize their boldest ambitions and create meaningful impact.